Sharonville biotechnology company Airway Therapeutics has raised another $15.5 million to help develop a drug to prevent and treat serious respiratory and inflammatory diseases.
Airway Therapeutics said it had closed an oversubscribed Series C financing round. The company was created in 2011 as a spin-out of Cincinnati Children’s Hospital, which is an investor in the company.
Click here to read the complete article.
Story excerpt provided by Cincinnati Business Courier.
Written by Barrett J. Brunsman.
Originally published January 8, 2020.